|
Q3 FY2026
As of Aug 2, 2026
|
Q2 FY2026
As of May 3, 2026
|
Q1 FY2026
As of Feb 1, 2026
|
Q4 FY2025
As of Nov 2, 2025
|
Q3 FY2025
As of Aug 3, 2025
|
Q2 FY2025
As of May 4, 2025
|
Q1 FY2025
As of Feb 2, 2025
|
Q4 FY2024
As of Nov 3, 2024
|
Q3 FY2024
As of Aug 4, 2024
|
Q2 FY2024
As of May 5, 2024
|
Q1 FY2024
As of Feb 4, 2024
|
Q4 FY2023
As of Oct 29, 2023
|
Q3 FY2023
As of Jul 30, 2023
|
Q2 FY2023
As of Apr 30, 2023
|
Q1 FY2023
As of Jan 29, 2023
|
Q4 FY2022
As of Oct 30, 2022
|
Q3 FY2022
As of Jul 31, 2022
|
Q2 FY2022
As of May 1, 2022
|
Q1 FY2022
As of Jan 30, 2022
|
Q4 FY2021
As of Oct 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Trade accounts receivable, net | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Long-term assets: | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Other long-term assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Employee compensation and benefits | ||||||||||||||||||||
| Current portion of long-term debt | ||||||||||||||||||||
| Short-term debt | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term liabilities: | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' equity: | ||||||||||||||||||||
| Preferred stock, $0.001 par value; 100 shares authorized; none issued and outstanding | ||||||||||||||||||||
| Common stock, $0.001 par value; 29,000 shares authorized; 4,774 and 4,741 shares issued and outstanding as of August 2, 2026 and November 2, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...
